Philip Morris
Passive Smoking in New Zealand
Fields
- Author
- Lee, P.N.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- Area
- SCIENTIFIC AFFAIRS/BLACK LATERAL OLD S&T
- Document File
- 2023511660/2023512308/Ets: Heart Disease 930900
- Litigation
- Okag/Privilege Withdrawn
- Okag/Produced
- Characteristic
- EXTR, EXTRA
- MARG, MARGINALIA
- Site
- R529
- Named Organization
- American Cancer Society
- New Zealand Medical Journal
- Author (Organization)
- New Zealand Medical Journal
- Pn Lee Statistics + Computing
- Named Person
- Hill
- Hirayama
- Kawachi
- Pearce
- Hirayama
- Master ID
- 2023511661/2307
Related Documents:- 2023511661-2307 Environmental Tobacco Smoke and Heart Disease
- 2023511710 the Relationship of Passive Smoking to Various Health Outcomes Among Seventh-Day Adventists in California.
- 2023511714-1718 Passive Smoking and the Risk of Heart Attack or Coronary Death
- 2023511722-1727 Effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers A Prospective Study
- 2023511728 Erratum
- 2023511729 'effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers: A Prospective Study'
- 2023511730 the First Author Replies
- 2023511734-1737
- 2023511738-1744 Passive Smoking in Females and Coronary Heart Disease
- 2023511749-1756 Original Contributions Heart Disease Mortality in Nonsmokers Living with Smokers
- 2023511760-1781 Lung Cancer in Japan: Effects of Nutrition and Passive Smoking
- 2023511785-1789 Passive Smoking and Cardiorespiratory Health in A General Population in the West of Scotland
- 2023511790 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511791-1792 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511793-1795 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511800-1802 Public Health Briefs Passive Smoking and 20-Year Cardiovascular Disease Mortality Among Nonsmoking Wives, Evans County, Georgia
- 2023511806-1816 Relationship of Passive Smoking to Risk of Lung Cancer and Other Smoking-Associated Diseases
- 2023511818 Increased Incidence of Heart Attacks in Nonsmoking Women Married to Smokers
- 2023511822-1824 Cvd Epidemiology Newsletter
- 2023511829-1841 Original Contributions Effects of Passive Smoking in the Multiple Risk Factor Intervention Trial
- 2023511842 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511843-1844 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511845 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511846 the Authors Reply
- 2023511849-1853 Smoking As A Risk Factor for Cerebral Ischemia
- 2023511857-1862 Urinary Cotinine Measurement in Patients with Buerger's Disease - Effects of Active and Passive Smoking on the Disease Process
- 2023511865-1881 An Estimate of Adult Mortality in the United States From Passive Smoking
- 2023511882 Editorial Cardiovascular Risks of Environmental Tobacco Smoke
- 2023511883-1887 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511888-1890 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511891-1892 Ischemic Heart Disease: Response to Lee
- 2023511893-1895 Rebuttal to Lee / Katzenstein Commentary on Passive Smoking Risk
- 2023511896-1899 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511900-1906 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response to Criticism
- 2023511908-1911 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511912 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511913 Passive Smoking in New Zealand
- 2023511914 Passive Smoking in New Zealand
- 2023511916 Passive Smoking and Passive Thinking
- 2023511918-1937 Cardiovascular Diseases and the Work Environment A Critical Review of the Epidemiological Literature on Chemical Factors
- 2023511939-1950 Clinical Progress Series Passive Smoking and Heart Disease Epidemiology, Physiology, and Biochemistry
- 2023511952-1957 Review Passive Smoking and the Risk of Heart Disease
- 2023511958-1961 Aha Medical / Scientific Statement Position Statement Environmental Tobacco Smoke and Cardiovascular Disease A Position Paper From the Council on Cardiopulmonary and Critical Care, American Heart Association
- 2023511965-1983 the Health Consequences of Involuntary Smoking A Report of the Surgeon General
- 2023511985-1998 Environmental Tobacco Smoke Measuring Exposures and Assessing Health Effects
- 2023512000-2015 Environmental Tobacco Smoke Proceedings of the International Symposium at Mcgill University 890000 Environmental Tobacco Smoke and Cardiovascular Disease: A Critique of the Epidemiological Literature and Recommendations for Future Research
- 2023512016-2028 Panel Discussion on Cardiovascular Disease
- 2023512030-2037 Indoor Air Quality and Ventilation Environmental Tobacco Smoke (Ets) and Cardiovascular Disease
- 2023512039-2054 A Critique of the Methods Used to Assess the Toxic Effects on Man of Combustion Products.
- 2023512056-2066 Coronary Heart Disease and Involuntary Smoking
- 2023512068-2077 7. Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512079-2088 Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512090-2091 Editorial Give A Dog-End A Bad Name
- 2023512093-2108 Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
- 2023512110-2129 Environmental Tobacco Smoke and Mortality A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked - 5 Heart Disease
- 2023512131-2155 Environmental Tobacco Smoke Exposure and Occupational Heart Disease
- 2023512157-2171 Passive Smoking and Coronary Artery Disease. Biological Plausibility and Severity of Effect
- 2023512173-2180 Carbon Monoxide and Cardiovascular Disease: An Analysis of the Weight of Evidence
- 2023512185-2189 the Effects of Passive Inhalation of Cigarette Smoke on Excercise Performance
- 2023512192-2195 Effect of Passive Smoking on Angina Pectoris
- 2023512199-2202
- 2023512203-2213 Effect of 'passive' Smoking on the Physical Load Tolerance of Coronary Heart Disease Patients
- 2023512216-2220 Indoor Passive Smoking: Its Effect on Cardiac Performance
- 2023512223-2224 Passive Smoking Severely Decreases Platelet Sensitivity to Antiaggregatory Prostaglandins
- 2023512227-2230 Platelet Sensitivity to Prostacyclin in Smokers and Non-Smokers
- 2023512233-2237 Besitzen Passivraucher Ein Erhohtes Thromboserisiko?
- 2023512241-2244 Passive Smoking Affects Endothelium and Platelets
- 2023512247-2253 Lipoprotein and Oxygen Transport Alterations in Passive Smoking Preadolescent Children the Mcv Twin Study
- 2023512256-2257 Abstracts of the 30th Annual Conference on Cardiovascular Disease Epidemiology Children's Hdl-Chol: the Effects of Tobacco: Smoking, Smokeless and Parental Smoking
- 2023512261-2266 Passive Smoking Alters Lipid Profiles in Adolescents
- 2023512269-2274 Serum Lipids & Lipoprotein Profiles of Cigarette Smokers & Passive Smokers
- 2023512278-2279 8th Worldconference on Tobacco or Health Building A Tobacco-Free World 920330 - 920403 Buenos Aires - Argentina Abstracts, Posters and Videos. Serum Lipoproteins in Nonsmokers Chronically Exposed to Tobacco Smoke in the Workplace
- 2023512282 the Association Between Carotid Arterial Wall Thickness and Active and Passive Cigarette Smoking
- 2023512285 Passive Smoking and Carotid Artery Wall Thickness: the Aric Study
- 2023512290-2297 Passive Smoking Increases Experimental Atherosclerosis in Cholesterol-Fed Rabbits
- 2023512300-2301 Supplement to Circulation Abstracts From the 65th Scientific Sessions New Orleans Convention Center New Orleans, Louisiana 921116 - 921119
- 2023512304-2307 Association of Passive Smoking with Increased Coronary Heart Disease Risk Is Not Explained by Elevation of Leucocyte Count
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- fic02a00
Document Images
11 OCTOBER 1989:
O~ Ca'7'7
NEW ZEALAND'MEDICA,LJOURNAll }' ') 539
presence: and found!that nalidiicic acid was contraindicated if there
was history of'convulsive disorders. I di.uontinued'nalidizic acid
and substituted cotrimoxazole.
I am happ!y to reporv the child has been free of'convulsions for
the last 5 weeks. Also there is a marked improvement in
personality with no evidence of hyperactivity. I am unable to,
predict whether the child will be free of convulsions and
hyperactivity in the future.
The lesson to be learnt from this experience is to listen to the
oncerns and observations of parents. They are with the child all
e time. We cannot remember the aide effects and
c~ntraindications of drugs all the time. If in doubt don't be
tlctant to refer to the text book even in the presence of patients.
Th ' bud'get and certifying fitness for work
The ' licy of a single benefit for people temporan'ly excluded from
the "d work force is good. Many factors hinder rehabilitation
and it `s unreal to pin it all on one. However the proposed greater
mone rewards for long term sickness disability w171 put more
press 'e on certifying doctors. I' personally find assessment of
sicknes disability more difficultthan accident. When one is paid
by the ' tient, one must do the best thing for that patient, who
often in 'rprets this in purely financial terms. 1 find that patients,
even one ' I have never seen before, often resent any attempt to
reassess 'sabilit- - v. Patients will go to the doctor who takes the
softest lin'. Clearll the budget proposals will not work unless
careful co ideration is given to the mechanism for determining
who is fit r work:
People eicluded from the paid work force for eight reasons:
Lack of su ble employment. Very few people with long term
disability are knable to do any sort of work. A caring;socoety would
resen,e suitab jobs for the disabled. Certifying somebody fit for
light w-ork is ile as sporting enthusiasts prefer these jobs too.
We are wedded the concept of a forty hour working week. There
would'be many vantages if twenty hour week employment were
moregenerally. a'ab1e: For many attempting rehabilitation this
would be a much kiore realistic initial goal: I am dismayed at tbe
budget target of 1 000 unemployed by the end of 1992. It would
be fairer to aim at 200 000 working only twenty hours a week.
Only the totall' vdis bled! should be exduded'from the work force.
Lack of training d skills. These are required for most jobs
suitable for people 'th disability. Retraining is the key to
rehabilitation.
Care of other perso . Many are excluded from the paid work
force by the needs ofch' dren and invalids. People often combine
these responsibilities w'th paidlemployment but only if their
health remains good;.
Lack of motic.ation. I u ually find that this is better described
as having given up hope. What use is rehabilitation if there is
no job? Where a patient asbeen on high wages the job that
follows is likely to be lower 'd. A major obstacle to rehabilitation
would result from the pro se.d earnings related compensationn
for long term sickness disa ` ity.
Place of residence. People w have given up hope often attempt
to make life bearable by mo , g to pleasant places. These are
likelv to be remote from rehab 'tation facilities or employment
opportunities. Others attempt relieve boredom by becoming
itinerant.
Congenital disabilities. illness. ccident. These last three are
the only causes that come into the of expertise of the medical i
profession: Even here we often the assistance of other
disciplines. Seldom are medical co di.tions the sole causes of
exclusion from the workforce. It' is impossible to aay wbetbeJ
rehabilitation is possible unless reha 7itation has been tried.
I accept that certification by a d acting alone is the only
practical way fon short term disabilit However I consider it
unwise for these certificates to be ' newable indefinitely;,
sometimes by a different doctor each ' . I propose that a time
limit of say six months be set. After that. ' sessment should be
by a multidisciplinary team, whose chief 'an is rehabl7itation.
Patients should be reviewed annually. Even' the medical cause
for exelusion from the workforce is unlik to improve, the
nonmedical causes may, I consider it wrong taI cliaats that
they are permanently useless:
Bruce Mackereth, Mercury Ba Health Centre.
Whrtunga.
Passive smoking in New Zealand
In replying:to my earlier letter (NZ Med J! 1989i 102: 448) Drs
Kawachi an& Pearce (NZ Med Ji 1989: 102: 479) misunderstand
some important issues. They suggest I have not grasped the
purpose of' metaanalysis. because I' pointed out many of the
studies of passive smoking and heart disease are very small. Nott
so; I was making, it dear the overall' meta-analysis would be
dominated by the two large studies; based on more deaths 118521
than the other five studies combined (22fi1: and that there were
major doubts about the findings from both of these largeatudies.
Drs Kaw-achi and Pearce seem to understand my criticisms of
the Maryland study I11 but not my comment on the
inconsistency of the two reports from Huayams'a study 12.31.
Based on 14 years follow up and 406 heart disease deaths among
female nonsmokers, Hirsyama lg) reported relative risks.
standardised for age and occvpation, of 1. 0.97 and 1s03 according
to whether the husband was lil a nonsmoker. (iil an exsmoker or,
a smoker of 1-19 cigarettes a day, or (l'ti) a smoker of 20+ cigarettes
a day. Based on 17 years follow up and an extra 88 deaths.
Hirayama 13) reported relative risks, standardised for age, of 1,
1.10 and 1.30 for the same compariaona. If standardisation for.
oocupation had no effect, it can be estimated that the relative risks
for the last 3 years follow up would be 1 2.85 and 5.07; a
magnitude of effect inconsistent with his previous results and also
so large as to be totally implausible. If standardisation for
occupation did have an effecL why did Hirayama not standardise
for it in the later analysis?
The heart disease data. which contribute largely to the
estimated'bumber of deaths per year eaused'by passive smoking'.
are very unconvincing. The American Cancer Society million
person study has provided'the best evidence relating to apouse
smoking and lung cancer hl iand'it is unfortunate no similar data
on heart disease have ever been preseated. The study has far more
deaths in nonsmokers than the Japanese or Maryland studies,
and the quality of evidence is much superior.
Drs Kew-achi and Pearce say they cannot specifically comment'
on my elaim that misclassification of a proportion of smokers as
nonsmokers might explain Ilie observe& association between
passive smoking and lung cancer as two of my citations are to
papers given at conferences. This overlooks all' the other
references, one to a book (s) available since 1988 which contains
all the essential material. I have forwarded each of them a
complimentary copy:'
Drs Kaw-achi and Pearce quote the remark of Hill ls) that
consistencv, of an observation across different studies increases
confidence in the belief that the association is causal. This ignores
the possibility of a common source of bias affecting all the studies.
Mi.,rlassif,cation of smoking habits is just such a bias. Measuring
something 27 times with a faulty instrument is no better than
measuring 13 times. What is needed is an accurate instrument.
Until better studies are designed, estimates of deaths caused by
passive smoking based on meta-analysis are likely to be seriously
inaccurate.
The views I express do not necessarily reflect those of the
tobacco industry: Many organisations consult me, including some
tobacco companies, but the views I express are always my own,
and the only reason for expressing them is to promote scientific
understanding of issues of which I have expert knowledge.
Peter N Lee (Mrl:.
PN Lee Statistics and Computing Ltd.
Cedar Road.
Sutton,
Surrey SM2 5DA, UK.
'
'-A
_
n . '. 1..._ pr Ar_ f - _
t~_-r:~ht Law (lliti 17 L.S. GsA
1. H.1.~ a1.5.eAr DP. Cm.md Gw. Cb- E. H..rt dii..me.aR.titj ie mumakers
hvmW wifL. moi- . Am JEpid®mi ]98a. ,127: 91b22'.
t_ Hv.y.m..7..Am:eebe4 -w. d Mvy em4en b.v.. Y'i9hr n.kd k'.o9 oe~
mdry hm J.p.n.. Br l4.d J 19f:: 282: 1!J-s..
& HsW.e. T. t..M uear . J bp.a .E.cu d nuviuon .edd p..vs -ba[9 l- Mi..ll.
l[. Can.. P.,.da- t®9 ~ m.w .md p~uonN.. Y>t Vwf.g 41.~
1M/.am.t 1se4:,17s95:
Q G.rr.lalLiSo.omd.eYmYOnmmvWky,.mm9memt~.d.mump-
mki.g. J: Na emmr tsa 1981: ..E f061E6:.
L L.ePl4. )Aiad..ofinumdodcm b.biu md 1w.We wn1timg. AA r..r. df tbe
.vid~Q I.urna.ae.l. Atch- d Oo vWaaao.l .ed HL.hL 9uppl.mmL H.dN6~r
sprseA-V.l.g. 1969.
9. B~.Ma+d FLLti A.bul,u:tLoat d mdic.l ~r.:-Li^ 1,1U .Q lmdm-. Huddr md
sl 1964.
